Robert S. Breuil's most recent trade in CalciMedica Inc was a trade of 36,657 Restricted Stock Unit done . Disclosure was reported to the exchange on March 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 36,657 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 23 Mar 2023 | 36,657 | 48,003 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.50 per share. | 23 Mar 2023 | 12,677 | 35,326 | - | 5.5 | 69,724 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 5,000 | 163,849 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 5,000 | 30,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 14 Mar 2023 | 1,730 | 162,119 | - | 0.6 | 1,003 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 121,217 | 208,283 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 83,155 | 0 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 03 Mar 2023 | 49,434 | 158,849 | - | 0.6 | 28,177 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 28,125 | 393,750 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,937 | 89,438 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 5,000 | 35,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 5,000 | 88,795 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 12 Dec 2022 | 1,729 | 87,066 | - | 0.6 | 1,003 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 9,938 | 87,232 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 9,938 | 99,375 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.63 per share. | 01 Dec 2022 | 3,437 | 83,795 | - | 0.6 | 2,165 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2022 | 28,125 | 87,020 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Nov 2022 | 28,125 | 421,875 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 24 Nov 2022 | 9,726 | 77,294 | - | 0.7 | 6,516 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2022 | 5,000 | 60,579 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2022 | 5,000 | 40,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 04 Sep 2022 | 1,684 | 58,895 | - | 1.0 | 1,627 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 450,000 | 450,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 9,937 | 109,313 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 9,937 | 58,926 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 19 Aug 2022 | 3,347 | 55,579 | - | 1.0 | 3,247 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 5,000 | 48,989 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2022 | 5,000 | 45,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 39,750 | 119,250 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 39,750 | 60,279 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 19 May 2022 | 16,290 | 43,989 | - | 0.9 | 14,679 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 5,000 | 50,000 | - | - | Restricted Stock Units | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2022 | 5,000 | 22,717 | - | - | Common Stock | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 31 Mar 2022 | 2,188 | 20,529 | - | 1.3 | 2,735 | Common Stock |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 83,155 | 83,155 | - | - | Restricted Stock Unit | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 63,845 | 63,845 | - | - | Employee Stock Option (Right to Buy) | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| CalciMedica Inc | Robert S. Breuil | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 80,000 | 80,000 | - | - | Restricted Stock Units |